openPR Logo
Press release

Cardiac Biomarkers Market 2019 In-Depth Analysis of Industry Share, Size, Growth, and Key Players like Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Alere Inc., Becton, Dickinson and Company, Bio-Rad Laboratories.

02-20-2019 06:39 PM CET | Health & Medicine

Press release from: Allied Market Research

Cardiac Biomarkers Market 2019 In-Depth Analysis of Industry

The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with a heart. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infarction, congestive heart failure, acute coronary syndrome (ACS) among others.

Get the Sample Report:

Cardiac Biomarkers Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $2,085.9 million by 2020, registering a CAGR of 18.9% during the period 2015-2020. Cardiac Troponins (T, I) would continue to dominate the market throughout the forecast period due to high sensitivity and specificity.

Cardiac biomarkers are protein-based traceable substances used as an indicator of biological state for diagnostic and prognostic purposes associated with cardiac conditions. Commercialization of highly advanced and accurate type of cardiac biomarkers has provided a novel platform for the diagnosis of cardiac diseases. Continuous focus on pipeline research and developments from leading players and increased patient awareness across untapped regions such as India, China is largely driving the growth of cardiac biomarkers market.

The growing application of cardiac biomarkers as point of care (POC) testing facilitate quick results in chronic conditions, thus drives the market growth. However, specificity and sensitivity related concerns of single measurement cardiac biomarkers, premium pricing, and certain government regulations would hinder the market growth. Also, the overall market growth would bank on novel progress made in cardiac treatments using multi-assay biomarkers. The life-saving benefits of these multi-assay biomarkers would foster the revenue generation process as well as market penetration of novel cardiac biomarkers in the future.

For Purchase Inquiry:

Key findings of Cardiac Biomarkers Market:
• Troponin segment is projected as a leading market segment throughout the forecast period
• Revenue of myocardial infarction application segment is expected to grow almost threefold by 2020
• Laboratory location of testing market segment still dominates the global market
• Point of care location of a testing segment is projected to grow at a CAGR of 22% during the forecast period
• Countries like India and China holds prominent potential owing to a higher count of undiagnosed cardiac patients
• The principal strategy adopted by the leading players in the market is the product launch.

The key companies profiled in the report are
• Abbott Laboratories
• Alere Inc
• Siemens Healthcare
• Roche Diagnostics Corporation
• Beckman Coulter
• Becton
• Dickinson and Company
• Thermo Fisher Scientific
• BioMerieux
• Bio-Rad Laboratories
• Randox laboratories.

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Biomarkers Market 2019 In-Depth Analysis of Industry Share, Size, Growth, and Key Players like Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Alere Inc., Becton, Dickinson and Company, Bio-Rad Laboratories. here

News-ID: 1604522 • Views:

More Releases from Allied Market Research

Speech Analytics Market Expected to Reach to USD 4.9 Billion by 2031, Key Factors behind Market's Exponential Growth
Speech Analytics Market Expected to Reach to USD 4.9 Billion by 2031, Key Factor …
Allied Market Research published a new report, titled, " The Speech Analytics Market Expected to Reach to USD 4.9 Billion by 2031, Key Factors behind Market's Exponential Growth." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding
Artificial Intelligence in Construction Market Expected to Reach USD 8.6 Billion by 2031, Growing with at a CAGR of 34.1%
Artificial Intelligence in Construction Market Expected to Reach USD 8.6 Billion …
According to the report published by Allied Market Research, The Artificial Intelligence in Construction Market Expected to Reach USD 8.6 Billion by 2031, Growing with at a CAGR of 34.1%. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers valuable able guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining
Seaweed Extracts Market to See Competition Rise | $3.5 Billion by 2032
Seaweed Extracts Market to See Competition Rise | $3.5 Billion by 2032
The seaweed extracts market was valued at $2 billion in 2022, and is estimated to reach $3.5 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032. Request Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/A12569 Seaweed extracts refer to concentrated substances derived from different types of seaweed or marine algae. These extracts are obtained through various extraction methods, such as drying, grinding, or chemical processes, resulting in highly potent forms
Unified Communications as a Service Market Expected to Reach USD 118.8 Billion by 2031, Key Factors behind Market's Exponential Growth
Unified Communications as a Service Market Expected to Reach USD 118.8 Billion b …
Allied Market Research published a new report, titled, " The Unified Communications as a Service Market Expected to Reach USD 118.8 Billion by 2031, Key Factors behind Market's Exponential Growth." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain

All 5 Releases


More Releases for Cardiac

Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Stupendous Growth …
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Prophesy in 2025
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Cardiac Monitoring & Cardiac Rhythm Management Market Review and Forecast 2025
Crystalmarketresearch.com published “Cardiac Monitoring & Cardiac Rhythm Management Market By Component, Technology, Application, And End User - Global Industry Analysis And Forecast To 2025” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. The cardiac monitoring & cardiac rhythm management market is expected to be worth $XX billion by 2025. The market is largely driven by factors such as rising incidence of cardiovascular
Cardiac Monitoring & Cardiac Rhythm Management Devices Market
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are